Genome-wide single-nucleotide polymorphism array-based karyotyping in myelodysplastic syndrome and chronic myelomonocytic leukemia and its impact on treatment outcomes following decitabine treatment
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yi, Jun Ho | - |
dc.contributor.author | Huh, Jungwon | - |
dc.contributor.author | Kim, Hee-Jin | - |
dc.contributor.author | Kim, Sun-Hee | - |
dc.contributor.author | Kim, Sung Hyun | - |
dc.contributor.author | Kim, Kyoung Ha | - |
dc.contributor.author | Do, Young Rok | - |
dc.contributor.author | Mun, Yeung-Chul | - |
dc.contributor.author | Kim, Hawk | - |
dc.contributor.author | Kim, Min Kyoung | - |
dc.contributor.author | Kim, Hyeoung-Joon | - |
dc.contributor.author | Kim, TaeHyung | - |
dc.contributor.author | Kim, Dennis Dong Hwan | - |
dc.date.accessioned | 2021-08-12T01:18:27Z | - |
dc.date.available | 2021-08-12T01:18:27Z | - |
dc.date.issued | 2013-04 | - |
dc.identifier.issn | 0939-5555 | - |
dc.identifier.issn | 1432-0584 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/13821 | - |
dc.description.abstract | Decitabine is a hypomethylating agent with proven clinical efficacy in myelodysplastic syndrome (MDS). The current study analyzed the role of single nucleotide polymorphism array (SNP-A)-based karyotyping in prediction of clinical outcome in MDS or chronic myelomonocytic leukemia (CMML) patients following decitabine therapy. A total of 61 MDS/CMML patients treated with decitabine were evaluated with Genome-Wide Human SNP 6.0 Array using DNAs derived from marrow samples. The primary endpoint was the best response rate including complete (CR) and partial response (PR) with overall (OS) and event-free survival (EFS) as secondary endpoints. Best response was noted in 14 patients (26.4 %) out of 53 evaluated patients including 12 CR and two PR with median follow-up of 21.6 months. A total of 81 abnormal SNP lesions were found in 25 out of 61 patients (41.0 %). The patients carrying abnormal SNP lesions showed an inferior CR/PR rate (p = 0.002) and showed a trend of worse OS (p = 0.02 in univariate, p = 0.09 in multivariate) compared to those without SNP lesions, but not were associated with inferior EFS. The presence of abnormal SNP lesions in MDS was associated with adverse outcomes following decitabine therapy. Further study is strongly warranted to establish the role of SNP-A karyotyping in MDS. | - |
dc.format.extent | 11 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Springer Verlag | - |
dc.title | Genome-wide single-nucleotide polymorphism array-based karyotyping in myelodysplastic syndrome and chronic myelomonocytic leukemia and its impact on treatment outcomes following decitabine treatment | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1007/s00277-012-1635-7 | - |
dc.identifier.scopusid | 2-s2.0-84877070679 | - |
dc.identifier.wosid | 000316015500004 | - |
dc.identifier.bibliographicCitation | Annals of Hematology, v.92, no.4, pp 459 - 469 | - |
dc.citation.title | Annals of Hematology | - |
dc.citation.volume | 92 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 459 | - |
dc.citation.endPage | 469 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Hematology | - |
dc.relation.journalWebOfScienceCategory | Hematology | - |
dc.subject.keywordPlus | ACUTE MYELOID-LEUKEMIA | - |
dc.subject.keywordPlus | PROGNOSTIC IMPACT | - |
dc.subject.keywordPlus | HETEROZYGOSITY | - |
dc.subject.keywordPlus | MUTATIONS | - |
dc.subject.keywordPlus | AZACITIDINE | - |
dc.subject.keywordPlus | DELETION | - |
dc.subject.keywordPlus | LESIONS | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | COMMON | - |
dc.subject.keywordPlus | MDS | - |
dc.subject.keywordAuthor | Myelodysplastic syndrome | - |
dc.subject.keywordAuthor | Chronic monomyelocytic leukemia | - |
dc.subject.keywordAuthor | Single nucleotide polymorphism-based karyotyping | - |
dc.subject.keywordAuthor | Copy number alterations | - |
dc.subject.keywordAuthor | Copy neutral loss of heterozygosity (CN-LOH) | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.